Literature DB >> 26188543

Structural, morphological, and functional diversity of amyloid oligomers.

Leonid Breydo1, Vladimir N Uversky2.   

Abstract

Protein misfolding and aggregation are known to play a crucial role in a number of important human diseases (Alzheimer's, Parkinson's, prion, diabetes, cataracts, etc.) as well as in a multitude of physiological processes. Protein aggregation is a highly complex process resulting in a variety of aggregates with different structures and morphologies. Oligomeric protein aggregates (amyloid oligomers) are formed as both intermediates and final products of the aggregation process. They are believed to play an important role in many protein aggregation-related diseases, and many of them are highly cytotoxic. Due to their instability and structural heterogeneity, information about structure, mechanism of formation, and physiological effects of amyloid oligomers is sparse. This review attempts to summarize the existing information on the major properties of amyloid oligomers.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid fibril; Amyloid oligomer; Cytotoxicity; Protein aggregation; Protein misfolding

Mesh:

Substances:

Year:  2015        PMID: 26188543     DOI: 10.1016/j.febslet.2015.07.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  51 in total

Review 1.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

2.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

Review 3.  Recent progress on understanding the mechanisms of amyloid nucleation.

Authors:  Eri Chatani; Naoki Yamamoto
Journal:  Biophys Rev       Date:  2017-12-06

4.  Amyloid beta oligomers: how pH influences over trimer and pentamer structures?

Authors:  Carla A Paredes-Rosan; Diego E Valencia; Haruna L Barazorda-Ccahuana; Jorge A Aguilar-Pineda; Badhin Gómez
Journal:  J Mol Model       Date:  2019-12-13       Impact factor: 1.810

5.  Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.

Authors:  Jason Candreva; Edward Chau; Margaret E Rice; Jin Ryoun Kim
Journal:  Biochemistry       Date:  2019-12-30       Impact factor: 3.162

6.  Foldability of a Natural De Novo Evolved Protein.

Authors:  Dixie Bungard; Jacob S Copple; Jing Yan; Jimmy J Chhun; Vlad K Kumirov; Scott G Foy; Joanna Masel; Vicki H Wysocki; Matthew H J Cordes
Journal:  Structure       Date:  2017-10-12       Impact factor: 5.006

Review 7.  Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing.

Authors:  Simon Alberti; Anthony A Hyman
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-28       Impact factor: 94.444

8.  Impact of semen-derived amyloid (SEVI) on sperm viability and motility: its implication in male reproductive fitness.

Authors:  Vijay Kumar; Pradeep G Kumar; Jay Kant Yadav
Journal:  Eur Biophys J       Date:  2019-08-07       Impact factor: 1.733

Review 9.  Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.

Authors:  Claudio Soto; Sandra Pritzkow
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

10.  Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation.

Authors:  Rashmi Adhikari; Mu Yang; Nabanita Saikia; Colina Dutta; Wafa F A Alharbi; Zhiying Shan; Ravindra Pandey; Ashutosh Tiwari
Journal:  ACS Chem Neurosci       Date:  2020-04-02       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.